Preoperative High-resolution Magnetic Resonance Imaging Can Identify Good Prognosis Stage I, II, and III Rectal Cancer Best Managed by Surgery Alone: A Prospective, Multicenter, European Study
By F. Taylor, P. Quirke, R. Heald, B. Moran, L. Blomqvist, I. Swift, D. Sebag‐Montefiore, P. Tekkis, G. Brown. Annals of Surgery, 2011
607 citations recorded by the source corpus.
Subfields: Oncology, Radiology, Nuclear Medicine and Imaging, Surgery
View Paper: https://www.semanticscholar.org/paper/be4a8db2fcd847c180d6006b3abbe8e35566cc54
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- R. Beets-Tan
- M. Gollub
- D. Lambregts
- M. Maas
- B. Barbaro
- L. Curvo-Semedo
- C. Rödel
- R. Glynne-Jones
Citations in the corpus
- Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting (2017, background): “It has even been suggested that nodal staging by imaging should be discarded altogether, because of known staging inaccuracies and because it has been suggested that patients with ‘good prognostic’ tumours (defined on MRI as ≤cT3b stage without MRF involvement) have good outcomes regarding survival ”
- Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2017, positive): “This is particularly valid because data suggest a low risk of local recurrence if the surgeon routinely carries out good-quality TME and removes the mesorectal nodes en bloc [27, 51].”